CJC-1295/Ipamorelin 10mg

CJC-1295 No DAC + Ipamorelin 5mg/5mg – Research Peptide Blend

CJC-1295 (No DAC) and Ipamorelin are two peptides commonly studied together in research related to growth hormone signaling and metabolic pathways. This blend allows researchers to examine how these compounds may interact when used in combination to stimulate natural hormone signaling processes.

Because the two peptides act on different mechanisms within the growth hormone pathway, researchers often study them together to better understand how these signals may influence recovery processes, metabolism, and cellular growth pathways.

Blend Components

CJC-1295 (No DAC) 5mg

CJC-1295 without DAC is a modified growth hormone–releasing hormone (GHRH) analog. Researchers study this peptide for its role in stimulating the natural release of growth hormone through pituitary signaling pathways.

Research interest often focuses on:

• Growth hormone signaling
• Metabolic regulation
• Cellular growth pathways
• Hormone release patterns

Ipamorelin 5mg

Ipamorelin is a growth hormone secretagogue that works by activating ghrelin receptors, which can stimulate the release of growth hormone from the pituitary gland. Researchers often explore Ipamorelin because of its selective signaling within the GH pathway.

Research interest often focuses on:

• Ghrelin receptor signaling
• Growth hormone release pathways
• Metabolic regulation
• Hormone signaling studies

Research Focus

• Growth hormone signaling pathways
• Hormone release mechanisms
• Metabolic and recovery pathways
• Interaction between multiple hormone-regulating peptides

Product Details

• Multi-peptide research blend
• Lyophilized powder format for stability
• High-purity research compounds
• Packaged in sterile sealed research vials

⚠️ Disclaimer

This product is intended strictly for laboratory research purposes only.
Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.